Outset Medical Inc (OM)
3.61
+0.09
(+2.56%)
USD |
NASDAQ |
May 20, 16:00
3.61
0.00 (0.00%)
After-Hours: 19:13
Outset Medical Cash from Investing (TTM): 21.35M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 21.35M |
December 31, 2023 | 83.03M |
September 30, 2023 | 7.853M |
June 30, 2023 | -1.793M |
March 31, 2023 | -30.26M |
December 31, 2022 | -66.30M |
September 30, 2022 | -30.96M |
Date | Value |
---|---|
June 30, 2022 | -72.95M |
March 31, 2022 | -169.09M |
December 31, 2021 | -142.51M |
September 30, 2021 | -115.73M |
June 30, 2021 | -125.79M |
March 31, 2021 | -22.02M |
December 31, 2020 | 3.947M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-169.09M
Minimum
Mar 2022
83.03M
Maximum
Dec 2023
-47.23M
Average
-30.61M
Median
Cash from Investing (TTM) Benchmarks
AngioDynamics Inc | 124.52M |
Baxter International Inc | 3.217B |
Allurion Technologies Inc | -1.433M |
Perspective Therapeutics Inc | -48.19M |
Xtant Medical Holdings Inc | -8.037M |